Corbus Pharmaceuticals Holdings
Q2 2025 13F Holders
Symbol
CRBP
CUSIP
21833P301
Type
Equity
Class
COM NEW
Num filings
83
Total reported value, excl. options
$62.6 M
Compare 2025 Q2 to
2025 Q3
2025 Q1
2024 Q4
2024 Q3
2024 Q2
2024 Q1
2023 Q4
2023 Q3
2023 Q2
2023 Q1
2020 Q1
2019 Q4
Manager
Report Date
Value ($000)
Shares
Option Type